{
  "enhanced_kg_config": {
    "enable_enhanced_kg": true,
    "entity_distance_threshold": 0.85,
    "preserve_case_entities": [
      "SOFA",
      "DIC",
      "MAP",
      "WHO",
      "PR",
      "CVP",
      "MAOI",
      "ACE",
      "APACHE",
      "FDA",
      "MODS",
      "CCB",
      "ESC",
      "IO",
      "SSRI",
      "CKD",
      "SQ",
      "ICU",
      "ACCP",
      "ARDS",
      "NSAID",
      "AKI",
      "SL",
      "SCCM",
      "ECMO",
      "PCWP",
      "IM",
      "AHA",
      "IV",
      "IABP",
      "SVR",
      "SIRS",
      "ARB",
      "PO",
      "ET"
    ],
    "medical_domain_focus": true,
    "therapeutic_relationship_weights": {
      "therapeutic_effect": 0.9,
      "contraindication": 0.85,
      "drug_interaction": 0.8,
      "pharmacokinetic_pathway": 0.75,
      "monitoring_parameter": 0.7
    }
  },
  "medical_sample_queries": [
    "What are the pharmacokinetic parameters of vasopressors in septic shock?",
    "How do alpha-adrenergic agonists affect systemic vascular resistance?",
    "What are the monitoring parameters for norepinephrine therapy?",
    "How does vasopressin differ from catecholamine vasopressors?",
    "What are the contraindications for high-dose epinephrine?",
    "How does sepsis alter drug clearance and distribution?",
    "What are the hemodynamic targets in distributive shock?",
    "How do inotropes differ from vasopressors in mechanism?",
    "What biomarkers indicate adequate tissue perfusion?",
    "How should vasopressors be weaned in recovering patients?"
  ]
}